Historique
Article de Périodique
MDMA use by Paris medical students: Prevalence and characteristics (2021)
Auteur(s) :
BAZIN, B. ;
DUROY, D. ;
LEJOYEUX, M.
Année
2021
Page(s) :
67-71
Langue(s) :
Anglais
Domaine :
Drogues illicites / Illicit drugs
Discipline :
EPI (Epidémiologie / Epidemiology)
Thésaurus mots-clés
ETUDE TRANSVERSALE
;
MILIEU ETUDIANT
;
JEUNE ADULTE
;
MEDECINE
;
MDMA-ECSTASY
;
PREVALENCE
;
EXPERIMENTATION
Thésaurus géographique
FRANCE
;
VILLE DE PARIS
Résumé :
Background: 3,4-Methylenedioxy-N-methylamphetamine (MDMA) is increasing being used by youth in Europe and in France, but characteristics of its use are unknown.
Objectives: The aim was to characterize MDMA use in a sample of French medical students.
Methods: Cross-sectional study of Paris VII medical students (N = 592) with an online self-reporting questionnaire.
Results: 592 students completed the online questionnaire. 21.5% (n = 127) had experimented with MDMA. Use of MDMA was associated with male sex (p < 0.001), older age (p < 0.001), left the parent's home (p < 0.01), and belonging to a fraternity (p < 0.05). Most experimenters (90.7%) used MDMA in a club or during a music festival. Among users, 42.5% used it more than once a year and less than once a month. During the use, users drank alcohol (90.6%), smoked tobacco (70.9%), smoked cannabis (42.0%) or used cocaine (20.5%). In the days after the use, some smoked tobacco (40.9%), smoked cannabis (29.1%), drank alcohol (22.0%), used cocaine (1.6%) and also took benzodiazepines (5.5%). According to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, criteria, the prevalence of MDMA use disorder was 8.5% in our sample and 40.9% among MDMA users. As compared with students who never experienced MDMA, fewer users thought that occasional intake could be dangerous (66.9% vs 83.9%, p < 0.001) and that MDMA could be addictive (74.0% vs 90.3%, p < 0.001).
Conclusions: Other studies focusing on drug consumption among students are necessary to define specific public health strategies of prevention and harmful reduction.
Objectives: The aim was to characterize MDMA use in a sample of French medical students.
Methods: Cross-sectional study of Paris VII medical students (N = 592) with an online self-reporting questionnaire.
Results: 592 students completed the online questionnaire. 21.5% (n = 127) had experimented with MDMA. Use of MDMA was associated with male sex (p < 0.001), older age (p < 0.001), left the parent's home (p < 0.01), and belonging to a fraternity (p < 0.05). Most experimenters (90.7%) used MDMA in a club or during a music festival. Among users, 42.5% used it more than once a year and less than once a month. During the use, users drank alcohol (90.6%), smoked tobacco (70.9%), smoked cannabis (42.0%) or used cocaine (20.5%). In the days after the use, some smoked tobacco (40.9%), smoked cannabis (29.1%), drank alcohol (22.0%), used cocaine (1.6%) and also took benzodiazepines (5.5%). According to the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition, criteria, the prevalence of MDMA use disorder was 8.5% in our sample and 40.9% among MDMA users. As compared with students who never experienced MDMA, fewer users thought that occasional intake could be dangerous (66.9% vs 83.9%, p < 0.001) and that MDMA could be addictive (74.0% vs 90.3%, p < 0.001).
Conclusions: Other studies focusing on drug consumption among students are necessary to define specific public health strategies of prevention and harmful reduction.
Affiliation :
Department of Psychiatry and Addictive Medicine, Hôpital Bichat-Claude Bernard, Assistance Publique des Hôpitaux de Paris, Paris, France
Paris Diderot University-Paris VII, Paris, France
Paris Diderot University-Paris VII, Paris, France